Synthorx to Present at the European Society for Medical Oncology (ESMO) 2019 Congress

NEXT STORY
Auransa Presents New Preclinical Data on AU-409, a Novel, AI-Derived Drug Candidate for the Treatment of Hepatocellular Carcinoma
PREV STORY
First Data On Combination Of Enlivex’s Allocetra-OTS Immunotherapy and CAR-T Therapy Designed For Treating Solid Tumors Revealed At The Joint IIS-ISCR Special 2019 Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020

author_avatar
NASDAQ Market News

AngioSoma, Inc. Announces Grant of Patent for Flagship Drug

HOUSTON, TX, May 14, 2018 (GLOBE NEWSWIRE) -- AngioSoma, Inc. (OTC: SOAN) is excited to ...

author_avatar
NASDAQ Market News

BioSig’s Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota

author_avatar
NASDAQ Market News